Skip to content
Select language:
1800 620 420
Blood cancer information
How we can help
Get involved
Donate
Give monthly
Donate
Menu
Search
Home
Online Blood Cancer Support Service
Blood cancer information
COVID-19 & blood cancer
Blood cancer signs and symptoms
Types of blood cancer
Understanding your blood
What is blood?
The bone marrow & blood formation
The lymphatic system
Blood tests
Blood cancer statistics
Leukaemia
Acute myeloid leukemia (AML)
AML diagnosis
AML treatment
AML treatment side-effects
Acute lymphoblastic leukaemia (ALL)
ALL diagnosis
ALL treatment
ALL treatment side-effects
Acute promyelocytic leukaemia (APML)
APML diagnosis
APML treatment
APML treatment side-effects
Chronic myeloid leukaemia (CML)
CML diagnosis
CML treatment
CML treatment side-effects
Chronic lymphocytic leukaemia (CLL)
CLL diagnosis
CLL treatment
CLL treatment side-effects
Richter’s Syndrome
Hairy cell leukaemia (HCL)
HCL diagnosis
HCL treatment
HCL treatment side-effects
Biphenotypic leukaemia (BAL)
Lymphoma
Non-Hodgkin lymphoma (NHL)
NHL diagnosis
NHL treatment
NHL treatment side-effects
Adult T-cell lymphoma
Anaplastic large cell lymphoma
Burkitt’s lymphoma
Diffuse large B-cell lymphoma
Double hit lymphoma
Follicular lymphoma
Lymphoblastic lymphoma
Mantle cell lymphoma
Mucosa-associated lymphoid tissue lymphoma
Nodal marginal zone lymphoma
Peripheral T-cell lymphoma
Primary central nervous system lymphoma
Skin lymphomas
Small lymphocytic lymphoma
Hodgkin lymphoma (HL)
HL diagnosis
HL treatment
HL treatment side-effects
Myeloma
Myeloma diagnosis
Myeloma treatment
Myeloma treatment side-effects
Monoclonal gammopathy of unknown significance (MGUS)
Myelodysplastic syndromes (MDS)
MDS diagnosis
MDS treatment
MDS treatment side-effects
Chronic myelomonocytic leukaemia (CMML)
Deletion 5q
Myelodysplastic syndrome – RAEB
Refractory Anaemia with Ring Sideroblasts (MDS – RARS)
Refractory Cytopaenia with Unilineage Dysplasia (MDS – RCUD)
Myeloproliferative neoplasms (MPN)
MPN diagnosis
MPN treatment
MPN treatment side effects
Essential thrombocythaemia (ET)
Polycythaemia (rubra) vera
Primary myelofibrosis
Amyloidosis
Amyloidosis diagnosis
Amyloidosis treatment
Amyloidosis treatment side-effects
AL amyloidosis
Waldenstrom’s macroglobulinaemia (WM)
WM diagnosis
WM treatment
WM treatment side-effects
Aplastic anaemia
Aplastic anaemia diagnosis
Aplastic anaemia treatment
Aplastic anaemia treatment side-effects
Childhood blood cancers
Childhood lymphoma
Childhood lymphoma diagnosis
Childhood lymphoma treatment
Childhood lymphoma treatment side-effects
Childhood acute lymphoblastic leukaemia (ALL)
Childhood ALL diagnosis
Childhood ALL treatment
Childhood ALL treatment side-effects
Childhood acute myeloid leukaemia (AML)
Childhood AML diagnosis
Childhood AML treatment
Childhood AML treatment side-effects
Juvenile myelomonocytic leukaemia (JMML)
Childhood JMML diagnosis
Childhood JMML treatment
Childhood JMML treatment side-effects
Childhood MDS & MPN
Childhood MDS & MPN diagnosis
Childhood MDS & MPN treatment
Childhood MDS & MPN treatment side-effects
Children & blood cancer
The blood cancer journey
Newly diagnosed
What happens next?
Telling people
Your care team
Fertility & blood cancer
Pregnancy & blood cancer
Your healthcare rights
In active treatment
Treatment options for blood cancer
Chemotherapy
Stem cell transplants
Autologous stem cell transplants
Allogeneic stem cell transplants
Graft versus host disease (GVHD)
Sources of stem cell transplants
Haploidentical stem cell transplant
Targeted and biological therapies
Clinical trials
Guides to best cancer care
Wellbeing during treatment
Viruses & blood cancer
Diet & nutrition during treatment
Relationships & intimacy
Other side effects
Osteonecrosis of the jaw
Iron overload & iron chelation therapy
Peripheral neuropathy
Refractory cancer
Not in active treatment
Living with uncertainty
Going home after blood cancer treatment
Living well with blood cancer
Emotional health
Mental health
Relationships & sex
Practical matters
Returning to work or study
Managing your finances
Travel & holidays
Useful contacts
Food safety & nutrition
Grief & loss
Grief
Palliative care
Getting my affairs in order
Advance care planning
Legal matters
Managing your finances
Accessing superannuation
Seeking help
Useful contacts
Carers & friends
Online carers course
Supporting people with a blood cancer
Being a carer
Adjusting to being a carer
Day-to-day caring
Carers and the health system
Financial & legal support for carers
Carer resources
For healthcare professionals
Refer a patient for support services
Optimal Care Pathways for blood cancer
Order booklets and resources
Real stories
How we can help
Online Blood Cancer Support Service
Submit a request for support services
Accommodation services
About our accommodation services
Policies & reimbursements
Clem Jones – Sunland Blood Cancer Centre (Brisbane)
ESA Blood Cancer Centre (Brisbane)
Phillip Desbrow Leukaemia Foundation Blood Cancer Centre (Brisbane)
Village Green Blood Cancer Centre (Brisbane)
Queensland Freemasons Blood Cancer Centre (Townsville)
Sydney & Newcastle
Building of Hope Blood Cancer Centre (Melbourne)
Bridgestone Australia Blood Cancer Centre (Adelaide)
John James Blood Cancer Centre (Canberra)
Stirling Cross Apartments (Perth)
Transport services
Information & education services
Talking Blood Cancer Podcast
Download our information booklets
E-newsletters
Disease newsletter archive
Optimal Care Pathways for blood cancer treatment
Links to other resources
Order booklets and resources
Emotional support services
Health & wellbeing support services
Grief & bereavement support services
Online education & support
Assessment & referral services
Research
National Research Program
PhD scholarship recipients
Cancer Australia PdCCRS recipients
Strategic Ecosystem Partnership Grant recipients
Translational Research Program Grant recipients
Clinical trials
Clinical trials: FAQs
Blood Cancer Genomics Trial
The Trials Enabling Program
Trials Enabling Program FAQs
Clinical trial for Advanced Stage Hodgkin Lymphoma
Clinical trial for high tumour burden follicular lymphoma
Clinical trial for newly diagnosed AML or MDS with IDH1 or IDH2 mutation
Clinical trial for newly diagnosed AML or MDS with FLT3 mutation
Past research
Current funding opportunities
PhD Scholarships Program
PdCCRS Cancer Australia Grants
Research in action
Advocacy & policy
Optimal Care Pathways
Position statements
Federal Election 2022: Priorities for Blood Cancer
National Strategic Action Plan for Blood Cancer
Set the Standard for Blood Cancer
State of the Nation: Blood Cancers in Australia
Blood Cancer Taskforce
Get involved
Make a donation
World’s Greatest Shave
Fundraise
Create your own fundraiser
Join a community event
World’s Greatest Shave
Dry July
Join our Consumer Engagement Program
Blood stem cell (bone marrow) donation
Business partnerships
Partner with the Leukaemia Foundation
Our partners
In-kind sponsorship
Workplace Giving
Membership
Events
Previous webinars
Other ways to get involved
Donate your blood
Share your blood cancer story
Join our Branch network
Advocacy & policy
Make a donation
Donate
Donate to our Christmas Appeal
Become a regular giver
Donate in memory
Leave a gift in your Will
Will planning checklist
Gift in Will stories
Gift in Will FAQs
Workplace giving
Focused philanthropy
About us
Board & CEO
Ambassadors
Careers
Current vacancies
Annual reports & accounts
Position statements
Reconciliation Action Plan
News
Media releases
Media hub
Guidelines for reporting on Blood Cancer in Australia
Blood cancer facts & stats
Meet our executives & experts
Image & vision library
Media contacts
Stories
Lifeblood
E-newsletters
Subscribe to our news
Contact us
Close menu
Search
